tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

NLSP Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
11h ago
AKRO
ALLK
NLS Pharmaceutics Submits Research Abstracts to ASCP 2025
PremiumCompany Announcements
NLS Pharmaceutics Submits Research Abstracts to ASCP 2025
14h ago
6K
NLSP
NLS Pharmaceutics Launches Preclinical Program for Fentanyl Dependence Treatment
PremiumCompany Announcements
NLS Pharmaceutics Launches Preclinical Program for Fentanyl Dependence Treatment
3d ago
6K
NLSP
NLS Pharmaceutics and Kadimastem Move Toward Merger Approval
PremiumCompany Announcements
NLS Pharmaceutics and Kadimastem Move Toward Merger Approval
15d ago
6K
NLSP
Kadimastem calls for Special Meeting of Shareholders to approve NLS merger
PremiumThe Fly
Kadimastem calls for Special Meeting of Shareholders to approve NLS merger
15d ago
NLSP
NLS Pharmaceutics and Kadimastem Advance Merger Plans with $500,000 Fundraising
PremiumCompany AnnouncementsNLS Pharmaceutics and Kadimastem Advance Merger Plans with $500,000 Fundraising
23d ago
6K
NLSP
NLS Pharmaceutics Shareholders Approve Meeting Agenda
Premium
Company Announcements
NLS Pharmaceutics Shareholders Approve Meeting Agenda
23d ago
6K
NLSP
NLS Pharmaceutics and Kadimastem Move Forward with Merger Plans
Premium
Company Announcements
NLS Pharmaceutics and Kadimastem Move Forward with Merger Plans
1M ago
6K
NLSP
NLS Pharmaceutics, Kadimastem announce filing of F-4 Registration Statement
PremiumThe Fly
NLS Pharmaceutics, Kadimastem announce filing of F-4 Registration Statement
1M ago
NLSP
NLS Pharmaceutics Calls Extraordinary Meeting for Major Capital Restructuring
PremiumCompany Announcements
NLS Pharmaceutics Calls Extraordinary Meeting for Major Capital Restructuring
1M ago
6K
NLSP
NLS Pharmaceutics and Kadimastem Advance Diabetes Treatment with FDA Submission
PremiumCompany Announcements
NLS Pharmaceutics and Kadimastem Advance Diabetes Treatment with FDA Submission
1M ago
6K
NLSP
NLS Pharmaceutics, Kadimastem submit request for FDA pre-IND meeting
PremiumThe Fly
NLS Pharmaceutics, Kadimastem submit request for FDA pre-IND meeting
1M ago
NLSP
NLS Pharmaceutics Plans Capital Increase at Extraordinary Shareholders’ Meeting
PremiumCompany AnnouncementsNLS Pharmaceutics Plans Capital Increase at Extraordinary Shareholders’ Meeting
1M ago
6K
NLSP
NLS Pharmaceutics Advances DOXA Platform Amid Merger Plans
Premium
Company Announcements
NLS Pharmaceutics Advances DOXA Platform Amid Merger Plans
2M ago
6K
NLSP
NLS Pharmaceutics expects to close Kadimastem merger by end of January
Premium
The Fly
NLS Pharmaceutics expects to close Kadimastem merger by end of January
2M ago
NLSP
NLS Pharmaceutics Offers New Investment Opportunities
PremiumCompany Announcements
NLS Pharmaceutics Offers New Investment Opportunities
2M ago
6K
NLSP
NLS Pharmaceutics Unveils Promising Data for New Treatments
PremiumCompany Announcements
NLS Pharmaceutics Unveils Promising Data for New Treatments
2M ago
6K
NLSP
NLS Pharmaceutics announces preclinical data on DOXA platform
PremiumThe Fly
NLS Pharmaceutics announces preclinical data on DOXA platform
2M ago
NLSP
NLS Pharmaceutics Unveils Promising Narcolepsy Treatment
PremiumCompany Announcements
NLS Pharmaceutics Unveils Promising Narcolepsy Treatment
2M ago
6K
NLSP
NLS Pharmaceutics highlights preclinical program for AEX-41, AEX-2
PremiumThe FlyNLS Pharmaceutics highlights preclinical program for AEX-41, AEX-2
2M ago
NLSP
NLS Pharmaceutics AG Announces Share Capital Expansion
Premium
Company Announcements
NLS Pharmaceutics AG Announces Share Capital Expansion
3M ago
6K
NLSP
Kadimastem Ltd. Faces Financial Uncertainty
Premium
Company Announcements
Kadimastem Ltd. Faces Financial Uncertainty
3M ago
6K
NLSP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >